Skip to content

Comparison of analgesic effects between ultrasound-guided vertical spinal plane block and head neck hemispinalis plane block in posterior cervical spine surgery: a randomized, double-blind, non-inferiority controlled study

Comparison of analgesic effects between ultrasound-guided vertical spinal plane block and head neck hemispinalis plane block in posterior cervical spine surgery: a randomized, double-blind, non-inferiority controlled study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300076637
Enrollment
Unknown
Registered
2023-10-13
Start date
2023-12-01
Completion date
Unknown
Last updated
2023-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical spondylosis

Interventions

ISP group:Perform ultrasound-guided head neck hemispinalis plane block
ESPB group:Perform ultrasound-guided erector spinalis plane block

Sponsors

The Seventh Affiliated Hospital, Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Adults (= 18 years old) 2. American Society of Anesthesiologists (ASA) Grades I to III 3. Body mass index (BMI)<30 kg/? 4. Patients who choose to undergo posterior cervical spine surgery

Exclusion criteria

Exclusion criteria: 1. Patient refuses to participate in the trial 2. Severe organ dysfunction such as heart failure, respiratory failure, uremia, liver cirrhosis, etc 3. Individuals who are allergic to related anesthetic drugs 4. There are contraindications related to regional anesthesia (infection at the puncture site, severe coagulation dysfunction) 5. Individuals with a previous history of cervical spine surgery 6. Opioid drug abusers 7. Temporarily changing the surgical method 8. Individuals who are unable to communicate normally or cooperate with anesthesia (language communication disorders, intellectual disabilities, Alzheimer's, Parkinson's, etc.)

Design outcomes

Primary

MeasureTime frame
VAS score at rest 24 hours after surgery;

Secondary

MeasureTime frame
Total dosage of opioids ;Total dosage of muscle relaxants during surgery;Time of first postoperative activity on the ground;The incidence of postoperative adverse reactions;The incidence of postoperative and surgical related complications ;

Countries

China

Contacts

Public ContactChi Xinjin

The Seventh Affiliated Hospital, Sun Yat-sen University

chixinjin@sysush.com+86 189 2340 9020

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026